ES2151022T3 - Polvos secos estables que contienen hirudina. - Google Patents

Polvos secos estables que contienen hirudina.

Info

Publication number
ES2151022T3
ES2151022T3 ES95300361T ES95300361T ES2151022T3 ES 2151022 T3 ES2151022 T3 ES 2151022T3 ES 95300361 T ES95300361 T ES 95300361T ES 95300361 T ES95300361 T ES 95300361T ES 2151022 T3 ES2151022 T3 ES 2151022T3
Authority
ES
Spain
Prior art keywords
hirudine
dry powders
powders containing
stable dry
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95300361T
Other languages
English (en)
Inventor
Tudor Dr Arvinte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCP Gen Pharma AG
Novartis AG
Original Assignee
UCP Gen Pharma AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCP Gen Pharma AG, Novartis AG filed Critical UCP Gen Pharma AG
Application granted granted Critical
Publication of ES2151022T3 publication Critical patent/ES2151022T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Glanulating (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)

Abstract

EN LA PRESENTE INVENCION SE PRESENTA UNA COMPOSICION FARMACEUTICA DESHIDRATADA POR CONGELACION QUE CONTIENE HIRUDINA Y UNA SAL DE CALCIO Y/O MAGNESIO SOLUBLE EN AGUA.
ES95300361T 1994-01-26 1995-01-20 Polvos secos estables que contienen hirudina. Expired - Lifetime ES2151022T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9401448A GB9401448D0 (en) 1994-01-26 1994-01-26 Stable dry powders

Publications (1)

Publication Number Publication Date
ES2151022T3 true ES2151022T3 (es) 2000-12-16

Family

ID=10749332

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95300361T Expired - Lifetime ES2151022T3 (es) 1994-01-26 1995-01-20 Polvos secos estables que contienen hirudina.

Country Status (20)

Country Link
US (1) US5733874A (es)
EP (1) EP0665019B1 (es)
JP (1) JP3350604B2 (es)
KR (1) KR100360784B1 (es)
AT (1) ATE195426T1 (es)
AU (1) AU701886B2 (es)
CA (1) CA2140971C (es)
CY (1) CY2259B1 (es)
DE (1) DE69518342T2 (es)
DK (1) DK0665019T3 (es)
ES (1) ES2151022T3 (es)
FI (1) FI114141B (es)
GB (1) GB9401448D0 (es)
GR (1) GR3034816T3 (es)
HU (1) HU216628B (es)
IL (1) IL112389A (es)
NO (1) NO316883B1 (es)
NZ (1) NZ270384A (es)
PT (1) PT665019E (es)
ZA (1) ZA95576B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401447D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
DE19607239A1 (de) 1996-02-27 1997-08-28 Behringwerke Ag Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
KR20000070338A (ko) 1997-01-20 2000-11-25 나가시마 카쭈시게, 노미야마 아키히코 펩티드의 안정화 방법 및 당해 방법을 이용한 펩티드 함유 동결건조 의약조성물
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
WO2006138181A2 (en) 2005-06-14 2006-12-28 Amgen Inc. Self-buffering protein formulations
ES3064802T3 (en) 2016-10-21 2026-04-29 Amgen Inc Pharmaceutical formulations and methods of making the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243358B (it) * 1990-07-23 1994-06-10 Iketon Farmaceutici Srl Composizioni farmaceutiche per la somministrazione orale di irudina
JP2965359B2 (ja) * 1991-01-07 1999-10-18 積水化学工業株式会社 血液検査用容器
AU659432B2 (en) * 1991-03-08 1995-05-18 Novartis Ag A method for the inhibition or prevention of tumor cell metastasis with hirudin
GB9303275D0 (en) * 1993-02-18 1993-04-07 Ciba Geigy Ag Pharmaceutical compositions

Also Published As

Publication number Publication date
PT665019E (pt) 2001-01-31
ZA95576B (en) 1995-07-26
IL112389A0 (en) 1995-03-30
NO950274L (no) 1995-07-27
GB9401448D0 (en) 1994-03-23
HUT70474A (en) 1995-10-30
AU701886B2 (en) 1999-02-11
FI114141B (fi) 2004-08-31
US5733874A (en) 1998-03-31
JP3350604B2 (ja) 2002-11-25
AU1131895A (en) 1995-08-03
NO950274D0 (no) 1995-01-25
NO316883B1 (no) 2004-06-28
ATE195426T1 (de) 2000-09-15
JPH07267877A (ja) 1995-10-17
CY2259B1 (en) 2003-07-04
IL112389A (en) 2003-05-29
CA2140971A1 (en) 1995-07-27
GR3034816T3 (en) 2001-02-28
KR100360784B1 (ko) 2003-02-25
DE69518342D1 (de) 2000-09-21
HU216628B (hu) 1999-07-28
HU9500216D0 (en) 1995-03-28
CA2140971C (en) 2008-11-25
DE69518342T2 (de) 2001-02-01
NZ270384A (en) 1996-02-27
EP0665019B1 (en) 2000-08-16
DK0665019T3 (da) 2000-10-30
FI950282A0 (fi) 1995-01-23
EP0665019A1 (en) 1995-08-02
FI950282L (fi) 1995-07-27
KR950031105A (ko) 1995-12-18

Similar Documents

Publication Publication Date Title
FR2784294B1 (fr) Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique
DK1083912T3 (da) Antitrombotiske midler
NL194067B (nl) Farmaceutisch wateroplosbaar bruispreparaat dat N-acetylcysteine en aspartame bevat.
FR2778562B1 (fr) Composition pharmaceutique, hygienique et/ou cosmetique contenant de l'eau de mer et de l'arginine
GT199900180AA (es) Composicion farmacéutica para ser aplicada a las mucosas .
FI953310L (fi) Vesipitoisten liuosten desinfiointi
ES2077757T5 (es) Preparacion farmaceutica solida con disolucion rapida que contiene la n-acetilcisteina.
NO306450B1 (no) Farmasöytiske preparater med forlenget frigivelse av trimetazidin
EP0126791A3 (en) Solid body for the release of perfumes and/or disinfecting agents
ES2089613T3 (es) Composicion detergente.
DE69430458D1 (de) Hirudin enthaltende Arzneimittel
KR920014474A (ko) 담석 붕괴용 제제
ZA95576B (en) Stable dry powers
ES2037695T3 (es) Composiciones anticariogenas.
ES2092559T3 (es) Formulacion farmaceutica que contiene penciclovir.
AU570446B2 (en) Dipyridamole controlled release compositon
FR2718923B1 (fr) Composition désinfectante en solution aqueuse renfermant de l'orthophtalaldéhyde.
ES2070806B1 (es) Jarabe que contiene n-acetil-cisteina.
BR7900240U (pt) Configuração em botão de pressão
FR2747923B1 (fr) Composition contenant une benzodiazepine et un agent antipyretique, stabilisee par l'acide benzoique, un de ses sels ou l'un de ses derives
MX9704105A (es) Conjunto para uso en un ciclo terapeutico de tratamiento de la osteoporosis.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 665019

Country of ref document: ES